Abbreviations & Acronyms 99m Tc-DMSA = technetium99m dimercaptosuccinic acid CT = computed tomography eGFR = estimated glomerular filtration rate IQR = interquartile range RCV = renal cortical volume RPV = renal parenchymal volume SRF = split renal function SRV = split renal volume Objective: To evaluate the clinical application of computed tomography-based measurement of renal cortical volume and split renal volume as a single tool to assess the anatomy and renal function in patients with renal tumors before and after partial nephrectomy, and to compare the findings with technetium-99m dimercaptosuccinic acid renal scan. Methods: The data of 51 patients with a unilateral renal tumor managed by partial nephrectomy were retrospectively analyzed. The renal cortical volume of tumor-bearing and contralateral kidneys was measured using ImageJ software. Split estimated glomerular filtration rate and split renal volume calculated using this renal cortical volume were compared with the split renal function measured with technetium-99m dimercaptosuccinic acid renal scan. Results: A strong correlation between split renal function and split renal volume of the tumor-bearing kidney was observed before and after surgery (r = 0.89, P < 0.001 and r = 0.94, P < 0.001). The preoperative and postoperative split estimated glomerular filtration rate of the operated kidney showed a moderate correlation with split renal function (r = 0.39, P = 0.004 and r = 0.49, P < 0.001). The correlation between reductions in split renal function and split renal volume of the operated kidney (r = 0.87, P < 0.001) was stronger than that between split renal function and percent reduction in split estimated glomerular filtration rate (r = 0.64, P < 0.001). Conclusions: The split renal volume calculated using computed tomography-based renal volumetry had a strong correlation with the split renal function measured using technetium-99m dimercaptosuccinic acid renal scan. Computed tomography-based split renal volume measurement before and after partial nephrectomy can be used as a single modality for anatomical and functional assessment of the tumor-bearing kidney.
Introduction
Partial nephrectomy is currently the gold standard surgical procedure for managing small renal tumors. The success of this procedure depends on not only oncological outcomes, but also preservation of as much renal parenchyma as possible. [1] [2] [3] Two major methods are used to evaluate postoperative renal function: (i) serial measurements of serum creatinine to calculate the eGFR; and (ii) nuclear renal scan. Although many studies have shown the importance of eGFR change in renal functional evaluation after partial nephrectomy, there are limitations in its use in cases of nephron-sparing surgery for a small renal mass. 4, 5 For example, a patient with both kidneys could show no significant eGFR change after surgery if minimal renal parenchyma has been removed and irreversible ischemic injury has been avoided. In addition, contralateral compensatory hypertrophy after partial nephrectomy can minimize postoperative GFR decrease in the two-kidney model. 6 As serum creatinine measurements and eGFR calculation cannot reflect the decreased renal function of the operated kidney, traditionally nuclear renal scan has been used to evaluate postoperative renal function. [7] [8] [9] [10] Among various types of nuclear renal scans, the 99m Tc-DMSA renal scan is accepted as the most reliable method for quantifying cortical function and measuring the SRF. 11, 12 In addition, as 99m Tc-DMSA cannot bind to renal tumor tissue, it is also used to visualize or distinguish the renal tumor from normal renal parenchyma. 13 Recent studies have compared SRV estimated by CT datasets with SRF estimated by nuclear renal scan in living kidney donors for renal transplantation. [14] [15] [16] These studies have shown a significant correlation between SRF and SRV estimated by the two methods (r = 0.46-0.93). As the quantity of the preserved parenchyma is an extremely strong independent predictor of ultimate renal function after nephron-sparing surgery, 17 this approach was also applied to postoperative renal function evaluation in patients who underwent partial nephrectomy. 18, 19 The aim of the present study was to evaluate the clinical application of CT-based measurement of RCV and SRV in patients with renal tumors before and after partial nephrectomy, and compare the findings with 99m Tc-DMSA renal scan data.
Methods Patients
After receiving institutional review board approval (PNUH IRB E-2016095), we identified 235 patients who had undergone partial nephrectomy by a single surgeon at Pusan National University Hospital from 1 January 2008 to 1 January 2014. Of the 235 patients, we included 51 patients who had not only preoperative 99m Tc-DMSA renal scan and contrast-enhanced CT scan data, but also at least 12 months' postoperative 99m Tc-DMSA renal scan and contrast-enhanced CT scans follow-up data. Using 99m Tc-DMSA renal scans, we measured relative uptake for estimating the SRF of each kidney. Clinical data on demographic characteristics, the surgical procedure, and preoperative and follow-up medical records were retrospectively collected in a computerized database.
RCV and SRV measurements
Using contrast-enhanced CT scans carried out preoperatively and postoperatively, the RCV of the tumor-bearing kidney and contralateral kidney was measured using ImageJ software (National Institutes of Health, Bethesda, MD, USA) by a single reviewer. Previous reports have used this software for renal parenchymal and liver volume measurement. 20, 21 We used Measure Stack (OptiNav, Bellevue, WA, USA), which is an ImageJ plugin, to carry out measurements on a series of distinct regions of interest in the slices of a stack. CT images of the early arterial phase, which is 30 s after the contrast injection, were used in the analysis. The CT images, with a slice thickness of 3.8-5 mm, were saved in the digital imaging and communications in medicine format. With ImageJ software and the plugin, the enhanced renal cortex contour was semi-automatically outlined by applying a click on the renal cortex at each slice, excluding the pelvicaliceal system, renal sinus fat and vessels, and renal tumors and cysts (Fig. 1) . The software automatically multiplied the outlined area by the slice thickness to give the cortical volume of one slice. The RCV of the entire kidney was automatically calculated by the summation of the cortical volumes in each slice. Volume measurement for each kidney required an average of 5 min. The SRV of the tumor-bearing kidney was calculated as follows: SRV of tumor-bearing kidney (%) = (RCV of tumor-bearing kidney 9 100) / (RCV of tumor-bearing kidney + RCV of non-tumor-bearing kidney). The SRV of the contralateral non-tumor-bearing kidney was also calculated using this equation.
Renal functional evaluation
All serum creatinine levels were measured at a single clinical reference laboratory. The Modification of Diet in Renal Disease formula; that is, GFR (mL/min/1.73 m 2 ) = 186 9 (serum creatinine) À1.154 9 (age) À0.203 9 (0.742 if female), was used to calculate the total eGFR preoperatively and at each postoperative clinical visit. 22 Chronic kidney disease was defined as an eGFR of <60 mL/min/1.73 m 2 , 23 and no chronic kidney disease patient was enrolled in the analysis. As all patients had a contralateral non-tumor-bearing kidney, SRF calculated by 99m Tc-DMSA renal scans data was used to calculate split eGFR for each kidney. The split eGFR of the tumor-bearing kidney was calculated as follows: split eGFR of tumor-bearing kidney (mL/min/1.73 m 2 ) = total eGFR 9 (SRF of tumor-bearing kidney / 100).
Preoperative Postoperative 
Statistical analysis
Variables are presented as means with standard deviations, medians with IQR, and counts with percentages or proportions. To assess the relationship between quantitative datasets, Student's t-test was used. Pearson's correlation coefficient was used to determine the correlation between the different methods of renal function assessment. Bland-Altman plots were used to assess reliability and agreement between the different methods of renal function assessment. Statistical analysis was carried out with SPSS version 20.0 (IBM, Armonk, NY, USA) and GraphPad Prism 6 software (GraphPad Software, La Jolla, CA, USA). All statistics were considered significant at a P-value of <0.05.
Results

Patient population
The clinicopathological characteristics of the 51 patients are listed in Table 1 . Among the 51 patients, 49 had renal cell carcinoma, one had angiomyolipoma and one had oncocytoma. The male to female ratio was 2:1. The median pathological maximal tumor diameter was 3 cm (IQR 1.2-6.3). For all the patients, open partial nephrectomy was carried out, maintaining a margin of approximately 0.5 cm around the tumor, and warm ischemia was used with a median duration of 17 min (IQR 11-23). The pathological reports confirmed a negative surgical margin in all patients.
Volumetric data based on CT scans and functional data measured with 99m Tc-DMSA renal scans and split eGFR Comparison between SRF measured with 99m Tc-DMSA renal scan and SRV calculated by RCV
The mean preoperative SRF of the tumor-bearing kidney was 49.46 AE 3.97% before surgery, and it decreased to 41.55 AE 6.36% after surgery. A similar result was observed for SRV. The mean preoperative SRV of the operated kidney was 49.71 AE 3.53%, and it decreased to 42.17 AE 6.10% after surgery. A strong statistically significant correlation was observed between the preoperative SRF and SRV of the tumor-bearing kidney (r = 0.89, P < 0.001; Fig. 2a ). The postoperative SRV and SRF of the tumor-bearing kidney also showed a strong correlation (r = 0.94, P < 0.001; Fig. 2b ).
The Bland-Altman plot showed that the mean difference between preoperative SRV and SRF for the tumor-bearing kidney was À0.24 AE 1.82%, with a maximum difference of 6.30% (Fig. 2c) . The postoperative SRF was on average 0.61 AE 2.16% lower than postoperative SRV (Fig. 2d) . Limits of agreement suggested that the difference between the two methods was between À4.86 and 3.63 for approximately 95% of the cases. 2 , and it decreased to 33.27 AE 9.54 mL/min/1.73 m 2 after surgery. However, the contralateral kidney showed an average of 0.35 AE 9.37 mL/ min/1.73 m 2 (2.54 AE 17.04%) increase in split eGFR after surgery. The preoperative and postoperative renal function of the tumor-bearing kidney, measured by using split eGFR, showed moderate correlation with SRF (r = 0.39, P = 0.004 and r = 0.49, P < 0.001, respectively; Fig. 3 ).
Correlation of postoperative SRF reduction with postoperative split eGFR and SRV reduction
The mean reductions in SRV and SRF for the operated kidney were 7.53 AE 4.58% and 7.90 AE 4.56%, respectively. The mean percent reduction in split eGFR of the operated kidney was 25.57 AE 13.62% (11.40 AE 7.94 mL/min/ 1.73 m 2 ). The correlation between reductions in SRF and SRV (r = 0.87, P < 0.001) was stronger than the correlation between reduction in SRF and percent reduction in eGFR (r = 0.64, P < 0.001; Fig. 4a,b) . The Bland-Altman plot showed that the mean difference between postoperative reductions in SRV (%) and SRF of the tumor-bearing kidney (%) was 0.35 AE 2.29%, with a maximum difference of 6.28% (Fig. 4c) .
Correlation of warm ischemic time with postoperative reduction in SRF, split eGFR and SRV
The median duration of warm ischemia was 17 min (IQR [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . No significant correlation was observed between warm ischemic time and reductions in SRF (r = 0.26, P = 0.062). Both postoperative reduction in split eGFR and SRV were not correlated with the duration of warm ischemia (r = 0.19, P = 0.173 and r = 0.15, P = 0.283, respectively). 
Discussion
The present study provides novel data on the correlation between SRV calculated from RCV and SRF measured using 99m Tc-DMSA renal scan. Although the traditional model for quantifying postoperative renal function has relied on serial measurements of serum creatinine to calculate the eGFR, the present data showed that SRV change was more significantly correlated with SRF change than split eGFR change (r = 0.87 and r = 0.64, respectively). There are several reasons for this discordance. First, as serum creatinine levels are affected by not only renal function, but also other factors including the rate of creatinine biosynthesis and overall plasma volume, the serum creatinine concentration does not accurately reflect eGFR. 24 Second, serum creatinine and eGFR levels cannot account for the compensatory influence of the contralateral kidney in the two-kidney model with a small renal mass. 6 Indeed, our data show the increase in mean RCV and mean split eGFR of the contra lateral nontumor-bearing kidney (0.53 AE 1.21 cc and 0.35 AE 9.37 mL/ min/1.73 m 2 , respectively). This result implicates the compensated hypertrophy of the contralateral kidney.
To overcome the limitation of serum creatinine-based renal function evaluation, several studies have reported the usefulness of CT-based renal parenchymal volumetry. 18, 19, 25 According to these reports, there was a significant correlation between mean percent RPV loss and the mean percent eGFR loss (r = 0.52-0.79). However, although several reports have compared CT-based volumetry with nuclear renal scan in living kidney donors, there is no such report for nephron-sparing surgery. [14] [15] [16] As nuclear renal scans provide more accurate information about functional renal parenchyma, it is noteworthy that a stronger significant correlation was found between CT-based volumetry and nuclear renal scan.
There are three ways to use CT-based renal parenchymal volumetry: RPV, RCV and ellipsoid methods. 25, 26 Although the ellipsoid approach is a simple method to estimate renal volume using the ellipsoid volume formula, it is impossible to measure the functioning renal parenchyma exclusively, because of the difficulty in omitting the collecting system, renal sinus fat and vessels. The main difference in RPV and RCV measurements is whether or not the medullary region is included. 27 In other words, whereas the former uses the venous phase of contrast-enhanced CT, the latter uses the early arterial phase of the CT scan. We used RCV to calculate SRV, because of the methodological similarity between the 99m Tc-DMSA renal scan and CT-based RCV measurement. The proposed mechanisms of 99m Tc-DMSA uptake in the kidney are peritubular extraction or absorption of plasma protein-bound 99m Tc-DMSA directly from the blood into the proximal tubular cells or glomerular filtration, followed by tubular reabsorption. 12 Therefore, the 99m Tc-DMSA renal scan is primarily used to provide information on renal cortical morphology. 11, 12 Similarly, the early arterial phase of the contrast-enhanced CT scan provides distinguishable images of renal cortex from other renal parenchyma, such as renal medulla and collecting systems. As the majority of nephrons are located within, not the renal medulla, but the renal cortex, it is relevant to measure RCV for estimating the real functional volume rather than RPV. Indeed, a moderate relationship between eGFR and RCV, which was calculated by the early arterial phase of the contrast-enhanced CT scan, was reported. 27 In addition, like the 99m Tc-DMSA renal scan, the early arterial phase of the contrast-enhanced CT scan can successfully visualize the renal cortex, excluding renal tumors.
As postoperative renal function is mainly determined by the degree of parenchymal preservation when limited warm ischemia is used, it is important to measure and predict postoperative RCV for renal function evaluation. 17 Contrastenhanced CT scan in patients with renal tumors is the current recommended standard imaging modality before and after a surgical procedure. Besides providing anatomical information before surgery and local recurrence after surgery, physicians can use these CT scans to calculate and estimate postoperative functional renal cortex at no additional cost.
The main limitations of the present study were its retrospective design and a small cohort size. As we attempted to compare the postoperative CT scan with the nuclear renal scan, which was carried out at the same time, the study had a small cohort size. Another limitation of our analysis was the potential effects of the ischemic time during partial nephrectomy. However, we did not exceed the 25 min for renal artery clamping to minimize the effect of warm ischemia on the postoperative renal function. Furthermore, recent reports concluded that the ischemic time affects, not the long-term renal function, but the early event of renal function. 28, 29 Indeed, we measured RCV and SRV using the postoperative contrast-enhanced CT scans that were obtained at least 1 year after partial nephrectomy. After validation with a larger cohort, CT-based RCV measurement and SRV calculation could potentially be the best readily available method to evaluate not only the anatomical status of the renal tumor, but also the functional estimation of the tumor-bearing kidney.
